Cargando…
Pharmacological sex hormone manipulation as a risk model for depression
Sex hormone transition may trigger severe depressive episodes in some women. In order to map mechanisms related to such phenomena we developed a pharmacological preclinical human model using sex hormone manipulation with gonadotropin releasing hormone agonist (GnRHa) in a placebo‐controlled design....
Autor principal: | Frokjaer, Vibe G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383584/ https://www.ncbi.nlm.nih.gov/pubmed/32399989 http://dx.doi.org/10.1002/jnr.24632 |
Ejemplares similares
-
Role of emotional processing in depressive responses to sex-hormone manipulation: a pharmacological fMRI study
por: Henningsson, S, et al.
Publicado: (2015) -
Depression Associated With Hormonal Contraceptive Use as a Risk Indicator for Postpartum Depression
por: Larsen, Søren Vinther, et al.
Publicado: (2023) -
Functional and molecular neuroimaging of menopause and hormone replacement therapy
por: Comasco, Erika, et al.
Publicado: (2014) -
Mental Health Symptoms in Oral Contraceptive Users During Short-Term Hormone Withdrawal
por: Noachtar, Isabel A., et al.
Publicado: (2023) -
Family history of psychiatric disorders as a risk factor for maternal postpartum depression: a systematic review protocol
por: Kjeldsen, Mette-Marie Zacher, et al.
Publicado: (2022)